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PARTICIPATION IN RESEARCH AND THE CRPD 
 




This article discusses the implications of the United Nations’ Convention on the Rights 
of Persons with Disabilities (“CRPD”) for domestic policies on research involving persons 
with disabilities, including those with limited decision-making abilities. It starts with an 
examination of the protection the Convention affords to persons with disabilities against 
being enrolled in research projects, and argues that it does offer some such protection, 
but that the precise extent of this protection depends on conceptual and other matters 
that are not easily resolved by straightforward treaty interpretation. The article then 
proceeds with an analysis of whether the CRPD includes a right to participate in research 
projects on an equal basis with others. It argues that there are good reasons to interpret 
the CRPD to include such a right and explores its normative content. The article describes 
how the prohibition on discrimination delineates the scope for lawful exclusion of persons 
with disabilities in research studies and illustrates how discrimination analysis can be 
used to distinguish lawful practices from unlawful ones. It stops short, however, of 
drawing general conclusions about when exclusion is prohibited by the CRPD, arguing 
that this will depend on unresolved issues about the correct interpretation of the 
Convention’s right to legal capacity, and on an analysis of the rights and interests at 




Human subjects research,1 in various fields, is clearly important to societal progress. For 
such research to be possible, individuals obviously have to be provided with 
opportunities to participate in it. At the same time, participation is not always without 
risks or burdens. It is against a background of cases of serious harm to, and exploitation 
of, research subjects2 that international treaties, declarations and guidelines on research 
on human subjects have been developed.3 This fact helps to explain the focus on the 
protection of research participants in these documents, and the central role played by 
the requirement of free and informed consent.4 Protection is secured in part by 
provisions regarding the risks and burdens of research (assessment, monitoring, 
minimization, acceptability, etc). The requirement of consent is intended to ensure that 
research participants understand the risks and burdens involved in a project and that 
they and are nonetheless willing to take part in it. To this end, article 7 of the 
                                               
* Dr Anna Nilsson, Post-doctoral Fellow and Lecturer, Faculty of Law, Lund University; Dr Linus Broström, 
Lecturer in medical ethics, Department of Clinical Sciences in Lund, Lund University. 
1 That is, research involving human beings as research subjects and/or research participants. 
2 The term "research subject" is still extensively used, not the least in codes of research ethics. Often, but 
not always, "research participant" may be more appropriate. In this paper both terms will be used, with 
no substantive distinction intended unless otherwise indicated.  
3 See e.g. the discussion leading to the prohibition of scientific and medical experimentation without 
consent (Article 7 ICCPR) in Annotations on the Text of the Draft International Covenants on Human 
Rights [UN Doc A/2929]A/2929, Ch. VI, para. 14. [1 July 1955] 
4 Teresa Iacono and Rachel Carling-Jenkins, ‘The Human Rights Context for Ethical Requirements for 
Involving People with Intellectual Disability in Medical Research’ (2012) 56 (11) Journal of Intellectual 
Disability Research, 1124-5, [1122]. 
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International Covenant on Civil and Political Rights (“ICCPR”) prescribes that “no one 
shall be subjected without his free consent to medical or scientific experimentation”.5 
The Convention on Human Rights and Biomedicine (Oviedo Convention)6 and its 
Additional Protocol concerning Biomedical Research (Protocol on Biomedical Research)7 
clarify that participation in research presupposes that the individual has been provided 
with appropriate information as to the purpose and nature of the intervention, as well 
as its consequences and risks.8 They further state that research on persons lacking the 
ability to make free and informed decisions is only permitted if certain special safeguards 
are met.9 The Declaration of Helsinki (DoH), developed by the World Medical Association 
and having in many contexts acquired the status of soft-law, incorporates similar 
standards.10  
 
As indicated by the research governance just mentioned, ethical concerns have 
predominantly been raised about medical (or biomedical) research, and the regulatory 
safeguards put in place still relate, for the most part, only to those kinds of research. It 
is well-known, however, that ethically unacceptable or controversial research has been 
conducted outside of medicine, too. Quite a few studies in psychology, for instance, 
have elicited fear, anxiety, stress, embarrassment and similar effects at levels that 
cannot be considered innocuous, and have typically been conducted without fully 
informed consent.11 In sociology, anthropology and, again, psychology, various studies 
involving covert (sometimes participatory) observation have been conducted, where the 
privacy and reasonable expectations of research subjects have been violated in ways 
that could be questioned from an ethical perspective.12 And "field experiments" in 
economics, where researchers test what effects various manipulations of people's 
resources have on their acquisition and use of utilities they arguably need, have also 
raised ethical concerns.13 Accordingly, some legal instruments are broader in scope and, 
as reflected in the occasional dissatisfaction with the codification of ethical concerns in 
                                               
5 International Covenant on Civil and Political Rights (United Nations [UN]) 999 UNTS 171, UN Doc A/6316, 
UN Doc A/RES/2200(XXI), Annex, UN Reg No I-14668, [Signed] 16th Dec 1966; [Entered into Force] 23rd 
Mar 1976. 
6 Convention for the Protection of Human Rights and Dignity of the Human Being with regard to the 
Application of Biology and Medicine (Council of Europe) ETS No 164, 2137 UNTS 171, UNTS Reg No I-
37266 [Opened For Signature] 4th Apr 1997; [Entered into Force] 1st Dec 1999. 
7 (Council of Europe) CETS No 195 [Signed] 25th Jan 2005; [Entered into Force] 1st Sep 2007. 
8 Oviedo Convention, Article 15, and Protocol on Biomedical Research, Article 13. 
9 Oviedo Convention, Article 15, and Protocol on Biomedical Research, Article 17. 
10 World Medical Association, Declaration of Helsinki: Ethical Principles for Medical Research Involving 
Human Subjects (adopted June 1964, last revised 2013) paras. 26 and 28.  
11The Milgram obedience experiment probably being the most well-known one. Stanley Milgram, 
‘Behavioral Study of Obedience’ (1963) 67 Journal of Abnormal and Social Psychology 371. But see e.g. 
Allan J. Kimmel, Ethical Issues in Behavioral Research: Basic and Applied Perspectives, 2nd ed. (Blackwell, 
2007), ch. 3-4, for more examples. 
12 Laud Humphrey’s infamous study of sexual encounters between males in public restrooms, so called 
"tearooms", in the 1960s is a case in point. Laud Humphreys, Tearoom Trade: A Study of Homosexual 
Encounters in Public Places (Duckworth, 1970). Other examples are addressed in e.g. Brian Schrag, 
'Piercing the Veil: Ethical Issues in Ethnographic Research' (2009) 15 (2) Science and Engineering Ethics 
135-60; and Kimmel (fn 11 above), ch. 5. For an overview of the many ethical (and methodological) 
challenges with participant observation, see Thomas J. Roulet et al., ‘Reconsidering the Value of Covert 
Research: The Role of Ambiguous Consent in Participant Observation’ (2017) 20 (3) Organizational 
Research Methods 487-517. 
13 See e.g. Megan Blomfield, 'Ethics in Economics: Lessons from Human Subjects Research' (2012) 5 (1) 
Erasmus Journal for Philosophy and Economics, 24-44. 
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research14, other fields of research have increasingly had to adjust their practices to 
protective standards similar to those which researchers in medicine have to abide by. 
For example, Swedish legislation on research ethics15 applies not only to medical or 
biomedical research. It covers all research involving physical interventions, attempts to 
influence participants (physically or mentally), obvious risks of participants coming to 
harm (physically or mentally), or the processing of "special categories of" personal data 
(as defined by the EU General Data Protection Regulation).16 And while not legally 
binding, many influential ethics codes recognize the risk of harm and exploitation in 
those other fields as well, and include specific guidelines aimed to safeguard against 
various kinds of wrongdoing towards participants.17 
 
In 2008, the CRPD came into force.18 This treaty aims to ensure the full and equal 
enjoyment of human rights by persons with disabilities,19 and although it incorporates 
provisions on the need to protect persons with disabilities from exploitation and harm, 
other interests are arguably at the forefront of it. These include respect for individual 




In this article, we discuss some of the implications of the CRPD for domestic policies on 
research involving adult persons with disabilities, in particular persons with psychosocial, 
intellectual and cognitive disabilities, including impaired decision-making ability.20 Such 
policies could, of course, pertain to research on the subjects' impairments, but they may 
just as often concern research unrelated to these impairments.  
 
Our aim is to assess the extent to which the CRPD grants persons with disabilities (a) a 
right to participate in research and; (b) a right to protection against research enrolment. 
This assessment is timely and important. For one thing, the routine exclusion of certain 
groups from research projects obviously introduces a significant risk that many of the 
specific circumstances under which these groups live their lives remain under-
                                               
14 See e.g. Will C. van den Hoonaard and Ann Hamilton (eds.), The Ethics Rupture (University of Toronto 
Press, 2016). 
15 Swedish Act concerning the Ethical Review of Research Involving Humans (SFS 2003:460).  
16 Regulation (EU) 2016/679 [2016] OJ L119/1. The Swedish Act concerning the Ethical Review of 
Research Involving Humans (fn 15), § 13 requires that, in all of these cases, ethics review is mandatory 
and in the former three kinds of research, informed consent is required by all adult research participants 
capable of providing it. 
17 See e.g. The British Psychological Society, ‘Code of Human Research Ethics’ (2014); American 
Psychological Association, ‘Ethical Principles of Psychologists and Code of Conduct’ (amended 2010 and 
2016); section 8, American Sociological Association, ‘Code of Ethics’ (2018), Association of Social 
Anthropologists of the UK; and the Commonwealth, ‘Ethical Guidelines for Good Research Practice’ (2011), 
and the British Society of Criminology, ‘Statement of Ethics for Researchers’ (2015), section 4. 
18 Convention on the Rights of Persons with Disabilities, (United Nations [UN]) 2515 UNTS 3, UN Doc 
A/RES/61/106, Annex, GAOR 61st Session Supp 49, 65 [Adopted] 13th Dec 2006; [Opened for Signature] 
30th Mar 2007; [Entered into Force] 3rd May 2008. 
19 CRPD, article 1.  
20 The CRPD does not define disability or any sub-categories thereof, and terms like “mental”, 
“psychosocial”, “intellectual” and “cognitive” disabilities are used to refer to slightly different categories of 
people in human rights law scholarship. We adopt a broad understanding of the relevant terms, 
recognizing that there may be a certain an overlap between these categories and that persons with 
multiple impairments can fall under more than one of them.   
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investigated, limiting the development of new and improved services tailored to meet 
their needs.21 States party to the CRPD would then not fulfil their treaty obligations, and, 
more generally, it goes against the call from representatives of the disability movement 
for increased respect for personal choices.22 On the other hand, the treaty’s unequivocal 
condemnation of non-consensual experimentation on human beings reflects an ambition 
not to undo the hard-won protections of research subjects against harm and 
exploitation.23  
 
Now, the CRPD arguably has implications not only for whether persons with disabilities 
have a right to participate or not participate in research, but also for states parties’ 
policies on what kinds of research ought to be facilitated, and how, from a 
methodological standpoint, this research ought to be conducted. For example, there has 
been discussion within disability research about the value and prospects of participatory 
research designs.24 This and similar interesting issues, however, lie beyond of the scope 




The paper proceeds as follows: in Section 2, we ask what protection the CRPD provides 
for persons with disabilities against enrolment in research. Such protection is afforded 
by the Convention – explicitly, and sometimes implicitly – but its scope, we shall 
maintain, hinges on as yet unresolved issues about, inter alia, what counts as valid 
consent, and on the interpretation of (arguably vague) terms such as "experimentation", 
"integrity" and "exploitation".  
 
Section 3 discusses the extent to which the CRPD includes a right to participate in 
research. It contends that while several of the Convention's articles presuppose that 
persons with disabilities participate in research, they fall short of actually granting a right 
to such participation. We also argue, however, that the right to equal protection and 
benefit of the law guaranteed by article 5 amounts to a right to participate in research 
on an equal basis with others.  
 
Section 4 adds to the preceding and subsequent analysis by considering some of the 
potential reasons – legitimate or not – why researchers may decline to include persons 
                                               
21 The need to conduct research on issues that are important for marginalized groups have been discussed 
in relation to the right to enjoy the benefits of scientific progress included in the International Covenant 
on Economic, Social and Cultural Rights, (United Nations [UN]) 993 UNTS 3, CTS 1976/46, S Exec Doc D, 
95-2 (1978), GAOR 21st Session Supp 16, 49, UN Doc A/6316, UN Doc A/RES/21/2200, [Adopted] 16th 
Dec 1966; [Signed] 16th Dec 1966; [Entered Into Force] 3rd Jan 1976; Article 15.1(b). See e.g. Human 
Rights Council, ’Report of the Special Rapporteur in the field of cultural rights, Farida Shaheed: The right 
to enjoy the benefits of scientific progress and its applications’, A/HRC/20/26, paras. 15, 31, 43-44, (14 
May 2012). The Committee on the Economic, Social and Cultural Rights is currently developing a general 
comment on article 15 that will presumably clarify the scope of states’ obligations on this point. 
22 See e.g. Inclusion International, ‘Independent but not Alone: A Global Report on the Right to Decide’ 
(2014), World Network of Users and Survivors of Psychiatry (WNUSP); and Center for the Human Rights 
of Users and Survivors of Psychiatry (CHRUSP) ‘Response to Draft General Comment on Article 12’ (28 
February 2014): wnusp.wordpress.com/advocacy/legal-capacity/ [accessed 14 January 2020]. 
23 CRPD, article 15. 
24 See e.g. Mark Priestley, Lisa Waddington and Carlotta Bessozic, ‘Towards an Agenda for Disability 
Research in Europe: Learning from Disabled People’s Organisations’ (2010) 25 (6) Disability & Society 
731-47. 
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with disabilities in their research, and Section 5 explains how discrimination analysis can 
be used to distinguish lawful exclusion of persons with disabilities from research studies 
from discriminatory practices violating the CRPD. Here we argue that a proper 
discrimination analysis will involve balancing many different considerations, and that 
analyses will need, ultimately, to be made on a case by case basis. We end, in Section 
6, with some concluding remarks. 
 
II. CRPD AND THE RIGHT TO PROTECTION AGAINST RESEARCH ENROLMENT 
 
Several provisions of the CRPD protect persons with disabilities from enrolment in 
research that is unethical or that they do not wish to participate in. Article 15 (Freedom 
from torture or cruel, inhuman or degrading treatment or punishment) prohibits cruel, 
inhuman and degrading treatment in general and medical and scientific experimentation 
without the free consent of the person concerned in particular. Article 17 (Protecting the 
integrity of the person) includes a right to respect for the integrity of the person and 
article 16 (Freedom from exploitation, violence and abuse) obliges states parties to take 
action to protect persons with disabilities from exploitation and abuse. These provisions 
target different kinds of misconduct. Article 15 deals with the most flagrant offences. It 
is modelled on article 7 of the ICCPR, and it is clear from the negotiation records of the 
CRPD that the drafters foresaw that it would be interpreted in light of the meaning the 
corresponding article had acquired in the ICCPR.25  
 
Under the ICCPR, the prohibition of medical and scientific experimentation without 
consent has generated relatively little discussion. Rather than referring to a specific 
methodology, the term "experimentation" arguably denotes trying something out for the 
purpose of generating new knowledge. Hence, in the context of medicine, it serves to 
distinguish medical experimentation (or research) from medical treatment, which aims 
to improve the health of the person concerned.26 The article makes a distinction between 
medical and (other) scientific experimentation. What research practices (non-medical) 
scientific experimentation covers is not clear from the text or the preparatory works. 
Manfred Nowak’s commentary suggests, however, that essentially two types of 
malpractice are at issue: research on human subjects without consent, and research 
that causes significant harm to individuals or exposes them to great risks.27 This clearly 
includes experiments of the kind carried out in the concentration camps during the Nazi 
regime, for example,28 but the prohibition goes further; Nowak suggests that research 
on humans which leads to mutilation or other severe physical and mental suffering are 
impermissible, and other authors have interpreted the ICCPR in a similar vein.29  
 
Precisely how the line should be drawn between research practices which infringe article 
                                               
25 Daily Summaries of the Fifth Session of the Ad Hoc Committee related to article 11 Freedom from 
torture or cruel, inhuman or degrading treatment or punishment (28 January 2005), morning session, see 
recorded statements by Chile, the Russian Federation and the Coordinator. 
26 Cf. Manfred Nowak, U.N. Covenant on Civil and Political Rights: CCPR Commentary, 2nd rev ed. (N.P. 
Engel, 2005), 190.  
27 Ibid., 190-191.  
28 The travaux préparatoires to the ICCPR confirms that the drafters’ primary intention was to take a firm 
stand against the abhorrent experiments of totalitarian regimes conducted during World War II. General 
Assembly (fn 3 above) Ch. VI, para. 14. 
29 Nowak (fn 26 above), 191; and Sarah Joseph and Melissa Castan, The international Covenant on Civil 
and Political Rights: Cases, Materials and Commentary, 3rd ed. (OUP, 2013), [146]. 
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15 of the CRPD and research practices which do not violate this provision is unclear. 
Arguably, low risk studies that only cause slight psychological distress to their 
participants do not constitute ‘experimentation’ or ‘inhuman or degrading treatment’ in 
the specific senses these terms have in international human rights law, even if such 
studies are undertaken without proper consent from the persons concerned. But the 
point at which research interventions become invasive or harmful enough to be covered 
by article 15 may be difficult to determine. From a legal point of view, this issue may 
not be very important since practices that do not fall within the protective scope of article 
15 might nevertheless be prohibited by CRPD article 17, which stipulates that a person 
with disabilities has “a right to respect for his or her physical and mental integrity on an 
equal basis with others”. Questions can be raised about the scope of article 17 as well, 
of course; the treaty text provides no information that helps us to decide what kinds of 
research project interfere with a person's integrity. There is little doubt, however, that 
research involving some form of physical intervention, such as taking a blood sample or 
undergoing a physical examination, falls within the scope of article 17.30 Arguably, 
studies in which participants are asked to disclose sensitive information about their 
private lives or are observed in clearly private settings would also fall within the scope 
of this article.31  
 
It may be that some research studies are prohibited by the CRPD because they violate 
article 16. To what extent the latter article could be used to safeguard persons with 
disabilities against unethical research enrolment depends in part on its relationship to 
articles 15 and 17. The main issue here is whether article 16 offers protection which is 
independent of that offered by these other articles; that is, whether there could be 
exploitation or abuse in research, in the sense assumed by article 16, without there also 
being cruel, inhuman or degrading treatment, or a violation of a person's integrity. Just 
how strong protection article 16 offers, in this context, obviously also hinges on the 
extent to which persons with disabilities are seen as vulnerable to exploitation or abuse. 
That persons with disabilities are more vulnerable than others, all else being equal, is 
uncontroversial in the context of the CRPD.32 Precisely how vulnerable remains, 
however, an open question, and depends in part on one's views on the sources of such 
vulnerability; in particular, on the extent to which impairments and various social factors, 
respectively, contribute to it.33 It also depends on one's views on the "dignity of risk"34 
                                               
30 Cf. European Court of Human Rights, Y.F. v. Turkey, appn 24209/94, 22 July 2003, 39 EHRR 34, paras 
33-36. The case concerned a gynaecological examination without consent. The Court held that a person’s 
body concerns the most intimate aspect of “private life”, a concept which covers the physical and 
psychological integrity of a person. Thus, a compulsory medical intervention, even if it is of minor 
importance, constitutes an interference which must be justified to comply with the European Convention 
on Human Rights. 
31 It can be discussed whether research projects involving the processing of data from medical records or 
population-based registries only interfere with the protection of integrity in article 17 or also contravene 
the protection of privacy in article 22.2 of the CRPD. In human rights law, a clear distinction between the 
rights to respect for integrity and to privacy is not always upheld.  
32 This position has, however, been challenged in other theoretical and political contexts. The pitfalls of 
identifying especially "vulnerable groups" are for example brought to the fore by so called vulnerability 
theory. See e.g. Martha Albertson Fineman, ‘The Vulnerable Subject: Anchoring Equality in the Human 
Condition’ (2008) 20 (1) Yale Journal of Law and Feminism, 1-25.  
33 See for example Amanda Keeling, ’Article 16: Freedom from Exploitation, Violence and Abuse’ in Ilias 
Bantekas, Michael Ashley Stein and Dimitris Anastasiou (eds.) The UN Convention on the Rights of Persons 
with Disabilities: A Commentary (Oxford University Press, 2018), 475ff. 
34 Piers Gooding, 'Supported Decision-Making: A Rights-Based Disability Concept and its Implications for 
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in relation to exploitation; that is, whether concerns about overprotection of persons 
with disabilities should be seen as limiting the applicability of article 16. 
 
Taken together, the right not to be subjected to medical and scientific experimentation 
without consent, the right to equal respect for integrity and privacy, and states parties' 
obligation to prevent exploitation and abuse, on one level means that persons with 
disabilities benefit from the same protection against inclusion in unethical research as 
others. Nothing in the treaty text of the CRPD, or in the travaux préparatoires, suggests 
that these articles are intended to provide persons with disabilities with stronger (or 
weaker) protection from malpractice within the field of research than that afforded to 
persons generally. Thus, for example, persons with disabilities, just like everyone else, 
are protected against clinical research that could have been carried out on animals, that 
involves risks that are disproportionate to the potential benefits of the study, and that 
has not been approved by a research ethics committee.35 And, as already mentioned, 
persons with disabilities, like everybody else, must be protected from research enrolment 
without their free and informed consent.36 The fact the drafters appeared to aim for 
equal protection in these regards also means, however, that where research subjects 
are considered to have some particular vulnerability (situational or of another kind) 
additional safeguards may need to be put in place.37 For example, and as just 
mentioned, the "strength" and concrete implications of the protection offered by article 
16 depends on what we may legitimately assume about disabled persons' vulnerability 
to exploitation in the research context; which is a matter for continued discussion. In 
the next subsection, we shall also address article 12's take on equal protection when it 
comes to informed consent. 
 
Finally, complementing the specific safeguards in articles 15-17, the general prohibition 
of discrimination in article 5 (Equality and non-discrimination) protects against 
discriminatory inclusion of persons with disabilities in research studies. For example, to 
selectively enroll persons with intellectual disabilities in a potentially harmful or 
burdensome nutrition study for reasons related to researchers' convenience is not only 
wrong because it may expose the research participants to unacceptable risks, or risks 
that they may find difficult to assess. It also concentrates the harms and burdens of 
such research to persons with disabilities in a discriminatory manner. One could also 
imagine cases where articles 15-17 may not come into play, but where the prohibition 
of discrimination in article 5 nonetheless applies; cases, for example, where selective 
inclusion of persons with disabilities in a study will reinforce public prejudice against this 
group, and may cause stigma. 
 
                                               
Mental Health Law' (2013) 20 (3) Psychiatry, Psychology and Law 431, 435f.  
35 Cf. Oviedo Convention, Article 16, and its Protocol on Biomedical Research, Articles 5-7, and DoH, paras. 
16 and 23. 
36 Cf. Oviedo Convention, Article 16(v), and its Protocol on Biomedical Research, Article 14, and DoH, 
para. 25. 
37 Cf. UNESCO, Universal Declaration on Bioethics and Human Rights,  33 C/Res 74; [Adopted] 19th Oct 
2005, Article 8 (UDBHR); and DoH, para. 19. Examples of persons considered to be in need of additional 
safeguards include: prisoners and others deprived of their liberty; pregnant women; economically 
disadvantaged groups and persons suffering from ailments for which there is no satisfactory standard 
treatment. See Protocol on Biomedical Research, articles 12, 18 and 20, its explanatory report ‘Explanatory 
Report to the Additional Protocol to the Convention on Human Rights and Biomedicine, concerning 
Biomedical Research‘, Strasbourg, 25 January 2005, para. 69.   
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A. Protection against enrolment without consent 
 
As explained above, participation in research involving at least some kind of interference 
with integrity requires the free and informed agreement of the individuals concerned. 
What constitutes valid consent to research is not defined in the treaty text of the CRPD.38 
The negotiation records indicate that the appropriate formulation of the consent 
requirement was discussed during the drafting procedure, and that the phrase “free and 
informed consent” was chosen because it has an accepted meaning within human rights 
law.39 In other human rights instruments covering participation in medical research, 
consent to such participation implies an agreement to take part in a particular research 
project that was obtained without threats or improper inducements and after disclosure 
of the aim of the project and the possible risks and benefits involved. In the European 
context, this understanding of consent is codified in the (legally binding) Oviedo 
Convention and its Protocol on Biomedical Research.40 At the global level, it is embodied 
in the (not legally binding) UNESCO Declaration on Bioethics and Human Rights (UDBHR) 
and in bioethical declarations and guidelines developed by medical professionals and 
bioethicists, such as the DoH and the CIOMS guidelines.41 These documents further 
clarify that research participants should be informed of their rights, in particular the right 
to withdraw consent at any time without reprisals.42 Information should be provided in 
a comprehensible format to research participants.43 Before obtaining consent, 
researchers must also ensure that research subjects have understood the information 
provided,44 and in cases of doubt about an individual’s ability to understand the relevant 
information, arrangements must be in place to verify whether or not the person has 
such ability.45 Similar standards covering other fields of research can be found in various 
ethical guidelines.46 
 
Notably, many codes distinguish between persons who are able to provide consent and 
those who are not. Where persons considered to fall within the latter category are 
                                               
38 References to consent occur in several provisions of the treaty, i.e. in article 15 in relation to medical 
and scientific experimentation, in article 25(d) with regard to provision of health care and in article 23.1(a) 
in relation to marriage. None of these provisions, however, define the term. 
39 General Assembly, ‘Report of the Coordinator to the Ad Hoc Committee at its fifth session’, Annex II to 
the Fifth Session Report of the Ad Hoc Committee, 25 February 2005, A/AC.265/2005/2, para. 39 and 
Daily Summaries of the Fifth Session (fn 25) recorded statements by the Russian Federation, New Zealand, 
Jordan, Australia, Luxembourg (on behalf of the EU), the Coordinator and the Office of the High 
Commissioner for Human Rights. 
40 Oviedo Convention, Articles 5, 15 and16(iv), and its Protocol concerning Biomedical Research, Articles 
12-14. It should be noted that the Convention is ratified by 29 of the 47 Council of Europe Member States 
and that its Protocol is ratified by 11 States only.  
41 UDBHR, Article 6.2. See also DoH, paras. 25-26, and International Ethical Guidelines for Health-related 
Research Involving Humans, prepared by Council for International Organizations of Medical Sciences 
(CIOMS) in collaboration with the World Health Organization (WHO), guideline 9 (CIOMS guidelines).  
42 UDBHR, Article 6.2, Oviedo Convention, Article 5 and 16(iv-v), and its Protocol on Biomedical Research, 
Article 13.1 and 13.3, DoH, para 26, and CIOMS guidelines, guideline 9. 
43 UDBHR, Article 6.2, Protocol on Biomedical Research, Article 13.1, DoH, para. 26, and CIOMS guidelines, 
commentary to guideline 9. 
44 DoH, para. 26 and CIOMS guidelines, commentary to guideline 9. 
45 Protocol on Biomedical Research, Article 14.3 and CIOMS guidelines, commentary to guideline 16. 
46 Cf. The British Psychological Society, ‘Code of Human Research Ethics’ (fn 17 above), section 4, 
American Psychological Association (fn 17), ‘Ethical Principles of Psychologists and Code of Conduct’ 
(amended 2010 and 2016), section 8, and American Sociological Association, ‘Code of Ethics’ (fn 17), 
section 11. 
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concerned, these instruments permits exceptions to the rule that consent to research 
must be given by the research subject him- or herself. Persons who cannot consent may 
be enrolled in research projects if certain criteria are met. These are, roughly: the project 
has the potential to directly benefit the research subject; research of comparable 
effectiveness cannot be carried out on individuals capable of giving consent; and 
authorization has been given by a suitable third party (i.e. a legal representative or an 
authority).47 In addition, potential research subjects lacking the ability to consent must 
nevertheless be informed about the research and what participation involves, so that 
they are involved as much as possible in the decision-making procedure.  Also, the 
person must not object to participation.48 Many clinical research projects cannot be 
expected to produce direct health benefits for the participants, so it follows from the 
above that persons who cannot provide free and informed consent should as a rule be 
excluded from such projects. There is one exception to this rule, however, as enrolment 
is permitted if the project aims to benefit other persons with the same disease, disorder 
or condition and the research involves minimal risks and burdens for those involved.49  
 
The CRPD does not include standards at this level of detail, and questions about research 
participation received little attention during its negotiation.50 It is possible to interpret 
the CRPD in light of the above standards, and to construe it so that it allows for the 
enrolment of persons with limited decision-making skills if and only if the criteria outlined 
above are met; and certainly this approach has been taken by some states parties to 
the CRPD in their interpretative declarations.51 It is not entirely convincing, however. 
The protection package included in the Oviedo Convention, the DoH and several other 
codes is based on two assumptions: that some people – as a result of, for example, an 
impairment or a disease – lack the abilities necessary to provide legally valid consent to 
research, and that authorisation by a third party can compensate for such inability.52 
                                               
47 UDBHR, Article 7(b), Oviedo Convention, Article 17.1(ii-1v), Protocol on Biomedical Research, Article 
15.1(i-iii) and DoH, para. 28. Similar requirements are incorporated in the CIOMS guidelines, guideline 
16, and national regulations, such as the Swedish Act Concerning the Ethical Review of Research Involving 
Humans (fn 15 above) §§ 20-22.  
48 UDBHR, Article 7(b), Oviedo Convention, Article 17.1(v), Protocol on Biomedical Research, Article 
15.1(v) and DoH, para. 29. 
49 Oviedo Convention, Article 17.2, and Protocol on Biomedical Research, Article 15.2. UDBHR includes a 
similar limitation (in Article 7(b)), as does the DoH (paras. 28 and 30). A critical discussion of this provision 
can be found in Mats Johansson and Linus Broström, ‘Does Peer Benefit Justify Research on Incompetent 
Individuals? The Same-population Condition in Codes of Research Ethics’ (2012) 15 (3) Medicine, Health 
Care and Philosophy 287-94. 
50 The legitimacy of systems such as those envisaged in the Oviedo Convention was briefly discussed by 
a few states during the seventh session and then as part of a much broader discussion concerning the 
legitimacy of health interventions without the consent of the person concerned. Daily Summaries of the 
Seventh Session of the Ad Hoc Committee (19 January 2006), e.g. recorded statements by Norway and 
Yemen. 
51 France and the Netherlands have made interpretative declarations to the CRPD stating that they 
interpret the CRPD to permit enrolment of persons who are not able to consent in biomedical research if 
such enrolment is authorised by their representative or an authority or body provided and after the other 
protective measures included in human rights instruments have been undertaken. Full declarations 
available at: treaties.un.org/Pages/ViewDetails.aspx?src=TREATY&mtdsg_no=iv-
15&chapter=4&lang=en [accessed 14 January 2020] 
52 See e.g. Oviedo Convention, Article 17.1(iv), and its explanatory report ‘The Explanatory Report to the 
Convention for the protection of Human Rights and Dignity of the Human Being with regard to the 
Application of Biology and Medicine: Convention on Human Rights and Biomedicine’ Oviedo, 4 April 1997, 
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These assumptions are difficult to square with article 12 of the CRPD (Equal recognition 
before the law), at least under some influential interpretations of this article. Article 12.2 
protects the right of persons with disabilities to enjoy legal capacity (i.e. to make 
decisions and have them respected by the domestic legal order) on an equal basis with 
others in “all aspects of life”. The treaty text does not specify what this means in relation 
to persons with diminished capacity for understanding and reasoning, but the Committee 
on the Rights of Persons with Disabilities (CRPD Committee) has insisted that the 
possession of certain decision-making abilities is not a prerequisite of the right to enjoy 
legal capacity under the CRPD.53 Article 12.3 of the Convention does oblige states to 
ensure that persons with disabilities have access to the support they may require in 
exercising their legal capacity. Nothing in the treaty text, however, appears to imply that 
states parties are permitted to disqualify decisions made without such support. 
Accordingly, the Committee submits that article 12.2 obliges states to recognize the 
choices of persons with disabilities as legally valid also in situations where there is doubt 
about an individual’s ability to understand and weigh the relevant information and to 
appreciate the consequences of his or her decision.54  
 
While this interpretation can be contested, it certainly harmonises with the CRPD's 
emphasis, in article 3, on respect for autonomy and individual self-determination. 
Applying this line of argument to the subject matter discussed here, the implication is 
that consent to research that would not have qualified as sufficiently informed under, 
for example, the Oviedo Convention and the DoH, is legally valid under the CRPD. 
Clearly, if this is correct, the CRPD affords weaker protection against research enrolment 
than those other instruments in this respect. Moreover, the CRPD contains no specific 
rules limiting the scope for research enrolment of persons who cannot provide legally 
valid consent. Whereas the Oviedo Convention, the DoH, and several other codes 
prohibit research involving those with certain intellectual or cognitive disabilities 
whenever the relevant study could be conducted with those with no disabilities instead, 
the CRPD does not. Likewise, whilst those codes of research ethics limit the participation 
of a person who lacks the ability to consent to situations where he or she may directly 
benefit or is not exposed to more than minimal risks and burdens, the CRPD contains 
no such additional requirements for research participants with impaired decision-making 
ability. This is another respect, then, in which the CRPD affords weaker protection 
against research enrolment for persons with cognitive and intellectual disabilities. With 
the exception of situations where discrimination, exploitation or abuse is involved, the 
CRPD treaty text, for example, provides no rules preventing persons with disabilities who 
(with or without support) do not understand what's at stake from participating in risky 
research. In part this may be explained by the fact that the CRPD has a broad scope 
and is less specific on matters concerning research ethics, but it is also in line with the 
CRPD Committee’s refusal to hold some people to lack legal capacity.       
 
B. Protection through legal representation  
 
An intriguing question is whether the CRPD is compatible with domestic systems in which 
                                               
paras. 41, 43 and 105. See also the explanatory report to the Protocol on Biomedical Research (fn 37) 
paras. 69 and 85, and DoH para. 28 and 30. 
53 CRPD Committee, ‘General comment No. 1: Art 12: Equal recognition before the law’, adopted 11 April 
2014, CRPD/GC/1, paras. 13-15. 
54 Ibid.  
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a third party, often called a "legal representative", is mandated to decide on participation 
in research by persons who are believed to lack decision-making skills and who do not 
oppose such participation.55 The treaty text offers no clear-cut answer to this question; 
it neither authorises nor prohibits such systems per se. As alluded to above, the debate 
over the correct interpretation of the CRPD on matters concerning legal capacity is 
ongoing.  According to the CRPD Committee, the Convention prescribes that all forms 
of scientific and medical research on persons with disabilities must be based on the 
consent of those concerned, and argues that “such consent cannot be given via 
substituted decision-making”.56 In using the phrase “substituted decision-making”, the 
Committee is referring to systems in which legal capacity is removed from the potential 
research participant and transferred to a third party who has not been selected (or at 
least accepted) by the person concerned, or in which a third party is authorised to make 
decisions based on what is believed to be in the potential participant’s “objective best 
interest” as opposed to his or her “will and preferences”.57 It appears, then that the 
CRPD accepts support systems only where the third party is someone the potential 
participant has accepted or appointed (e.g. through power of attorney), and where the 
representative bases his or her decisions on the will and preferences of the person he 
or she represents.58 As noted above, some state parties have interpreted the convention 
differently, however.59 
 
The CRPD further prescribes that all measures relating to the exercise of legal capacity 
should provide for appropriate and effective safeguards to prevent abuse.60 This includes 
regular review of the system by a competent, independent and impartial authority or 
judicial body to ensure that any "legal representatives" or support persons respect the 
rights, will and preferences of the person with disabilities, and that the relationship 
between that person and his or her representative/supporter is free of conflict of interest 
and undue influence.61 Applied in the research context, this prohibits researchers from 
enrolling a person with disabilities in studies where this does not respect the latter’s will 
and preferences. It also prevents persons with an interest in a research project from 
representing or supporting prospective research subjects in the same project. 
Furthermore, article 12.4 disqualifies unethical representatives who seek to achieve a 
certain outcome by means of threats, deception or manipulation.62 Such safeguards are 
not explicitly mentioned in the previously discussed regulations focusing on research 
                                               
55 Persons who oppose participation in a research project must never be enrolled, regardless of their 
decision-making abilities, see fn 48 above.  
56 CRPD Committee, ‘Concluding observations on the initial report of Montenegro’, adopted 22 September 
2017, CRPD/C/MNE/CO/1, paras 34-35, ‘Concluding observations on the initial report of Costa Rica’, 
adopted 12 May 2014, CRPD/C/CRI/CO/1, paras 31-32, and ‘Concluding observations on the initial report 
of Italy’, adopted 6 October 2016, CRPD/C/ITA/CO/1, paras 39-40. 
57 CRPD Committee, ‘General comment No. 1’, para. 27. 
58 In cases where the person's will and preferences cannot be determined, even though significant efforts 
have been made, the Committee prescribes that a decision is made based on the "best interpretation of 
will and preferences". Ibid., para 21. 
59 See fn 51 above. See also declarations made by Australia, Canada, Estonia, Ireland and Norway 
regarding the lawfulness so called substitute decision-making.  
60 CRPD, Article 12.4. 
61 Ibid. 
62 CRPD Committee, ‘General comment No. 1’, para. 22. Precisely where the line between due and undue 
influence is to be drawn in the context of the support paradigm is an intricate question Cf. Lucy Series, 
'Relationships, Autonomy and Legal Capacity: Mental Capacity and Support Paradigms' (2015) 40 
International Journal of Law and Psychiatry 80-91, [88]. 
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ethics, for example the Oviedo convention or the DoH.63  
 
Comparison of the support system advocated by the CRPD Committee and that foreseen 
in, for example, the Oviedo Convention reveals significant differences. Under the Oviedo 
Convention, third-party authorisation is a prerequisite of the inclusion of persons who 
wish to participate in a research project (or do not object to such participation) but are 
deemed to lack the ability to make free and informed decisions on the matter.64 Without 
such authorisation, research on persons who cannot consent is unlawful. The CRPD 
contains no such authorisation requirement. Indeed, the support system envisaged by 
the CRPD Committee is a voluntary one, meaning that support must be made available 
to anyone who needs and wants it, but must never be imposed.65 Another set of 
differences revolve around the fact that the Oviedo Convention accepts (but does not 
prescribe) domestic systems of legal representation in which the person or body 
responsible for authorizing research participation is not selected by individual concerned 
and may not even be accepted by him or her. It also accepts systems in which legal 
representatives are permitted to base their decisions on what they believe to be in the 
individual's best interest.66 According to the CRPD Committee, such systems violate 
article 12 of the CRPD.67 Last, but not least, the CRPD prescribes that support systems 
must be subject to regular review and strengthened by appropriate and effective 
safeguards.68 The Oviedo Convention does not explicitly require monitoring of that kind.  
 
The differences listed above affect the circumstances under which the respective 
systems prescribe, or accept, the exclusion, from research, of persons who lack ability 
to consent to that research. Inclusion is permissible under the CRPD in some situations 
where it would not be permitted under the safeguards imposed by most codes of 
research ethics, but it is also prohibited by the Convention under some circumstances 
where those codes would permit inclusion. Whether these differences, with respect to 
legal representation, imply that one of the systems provides stronger protection than 
the other will depend, in part, on what one believes prospective research subjects ought 
to be protected against. The primary purpose of the CRPD support system is to ensure 
that persons with disabilities are not enrolled in research studies or provided with certain 
legal representation when this can be said to conflict with their will and preferences. The 
systems endorsed by the Oviedo Convention, the DoH, etc. have a different focus, 
aiming to protect persons with limited decision-making abilities from harms, risks and 
burdens of research participation even in situations where the individual appears to be 
willing to bear these burdens. How well the systems meet their aims in practice will 
depend, of course, on empirical issues – issues including the availability of decision-
making support and legal representation, and the quality of the services provided under 
the relevant arrangements.   
 
Although it remains an open question whether a support system or a system of legal 
                                               
63 Protocol on Biomedical Research, Article 12, however, obliges ethics committee to ensure that no undue 
influence is exerted on persons to participate in research. 
64 Oviedo Convention, Article 17(iv). 
65 CRPD Committee, ‘General comment No. 1’, paras. 18 and 29(b) and (g). 
66 The Oviedo Convention provide states with a fair amount of discretion when designing their systems in 
this regard. See the explanatory report to the Oviedo Convention (fn 52), para. 42. 
67 CRPD Committee, ‘General comment No. 1’, paras. 27, 29(b) and (g).  
68 CRPD, article 12.4. 
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representatives provides the most effective protection against enrolment in research 
studies, the discussion in Section 2.1 shows that many codes of research ethics impose 
stricter limits on research inclusion than those defined by the CRPD. On the other hand, 
the CRPD arguably provides persons with disabilities with a stronger right to contribute 
to research. Indeed, the CRPD Committee has expressed concern over the fact that 
some states parties have not taken appropriate action to ensure that persons with 
disabilities are permitted and enabled to consent to research.69  
 
To summarise, the CRPD protects persons with disabilities against unethical research 
enrolment. Article 5 protects against discriminatory enrolment. In addition, articles 15-
17 prohibit non-consensual experimentation, exploitative or abusive research practices, 
and studies that violate a person's integrity. The strength of this protection package 
depends on several factors, most notably on the interpretation of terms such as 
"experimentation", "exploitation" and "integrity". It also depends on how, in view of 
article 12, we conceptualise valid consent and on the design of the system for support 
or legal representation in place in the domestic context. The next section will discuss 
whether, and to what extent, the CRPD not only safeguards against involuntary 
enrolment, but creates an individual right to participate in research. 
 
III. CRPD AND THE RIGHT TO PARTICIPATE IN RESEARCH 
 
The first thing to note is that the Convention contains no explicit right to research 
participation. However, it sets out several rights and obligations which presuppose that 
persons with disabilities participate, in one way or another, in research. Article 31 
(Statistics and data collection), for example, insists that states parties collect 
information, including statistical and research data, to enable the formulation of 
adequate policies giving effect to the CRPD. Compliance with that article will, at a 
minimum, involve the processing of data on persons with disabilities, but in many cases 
it will also require persons with disabilities to be personally engaged, observed and/or 
exposed to interventions, and the like. Article 4 (General obligations) requires states 
parties to undertake or promote research on universally designed goods and services 
and to develop accessible information and communications technologies.70 Article 24 
(Education) requires states to set up inclusive education systems that maximize the 
academic and social development of disabled pupils and students.71 Similarly, articles 25 
(Health), 26 (Habilitation and rehabilitation), and 27 (Work and employment) oblige 
states to ensure that persons with disabilities have equal access to health care services,72 
to comprehensive rehabilitation and habilitation programmes,73 and to suitable 
vocational guidance and training programmes, respectively.74 To meet these obligations, 
states will need to develop an understanding of how best to ensure inclusive teaching, 
                                               
69 CRPD Committee, ‘Concluding observations on the initial report of Uganda’, adopted 12 May 2016, 
CRPD/C/UGA/CO/1, para. 28 and ‘Concluding observations on the initial report of Kenya’, adopted 30 
September 2015, CRPD/C/KEN/CO/1, paras. 29-30. 
70 CRPD, Articles 4.1 (f) and (g). 
71 CRPD, Article 24.1 and 24.2 (e). 
72 Article 25(a) and (b) obliges states parties to provide persons with disabilities with “the same range, 
quality and standard of free or affordable health care and programmes as provided to other persons” [our 
italics] and ensure that persons with disabilities have access to any health services they may need because 
of their impairment/ disability. 
73 CRPD, Article 26.1. 
74 CRPD, Article 27.1(d). 
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promote employment, secure equal access to adequate health interventions, etc., and 
there is little prospect of their doing so, with sufficient reliability, unless research 
involving persons with disabilities is conducted. Having said that, an obligation for states 
parties to conduct research on persons with disabilities will at most support a right for 
this group of persons to be involved in research: it does not ground any individual right. 
 
Article 9 (Accessibility) also has implications for the right to research participation. While 
it does not grant persons with disabilities a right to such participation per se, it obliges 
states parties to take steps to remove obstacles to whatever participation opportunities 
there would otherwise be. For example, states parties are obliged to put in place 
appropriate measures ensuring that research studies will – when necessary, and to the 
extent possible – make information material accessible to persons with disabilities, so 
that this group will not be excluded as the result of insufficient accessibility efforts being 
made by the state. Moreover, failure to take reasonable action to accommodate 
impairment or disability-related needs in individual cases violates the prohibition of 
discrimination: article 2 (Definitions) makes it clear that the denial of reasonable 
accommodation is a form of discrimination akin to direct and indirect discrimination; and 
article 5 paragraph 3 obliges states to ensure that reasonable accommodation is 
provided whenever it is needed.75 
 
Moreover, as has already been discussed, article 12.2 of the CRPD protects the right of 
persons with disabilities to exercise legal capacity on an equal basis with others. This 
includes the right to decide whether or not to participate in research; should an 
opportunity to be enrolled in a study present itself. Paragraph 3 entitles prospective 
research participants to the support they may need and want to express legally 
recognized consent. However, this provision does not imply a right to be invited to, or 
enrolled in, a particular research study; it merely ensures that whatever research 
opportunities are offered, the person with disabilities is to choose whether or not to take 
them. In the remainder of this section, however, we will argue that there are good 
reasons for interpreting the Convention to include, also, a stronger right – a right to 
participation in the development of new knowledge on an equal basis with others. This, 
if correct, implies that when research studies are being conducted they must be open to 
prospective participants with disabilities, if they are open to others. 
 
A. The right to participate on an equal basis with others 
 
Article 5 of the CRPD obliges states parties to ensure that persons with disabilities are 
entitled to equal protection and benefit of the law. To this end, states shall prohibit all 
discrimination on the basis of disability.76 The Convention defines disability-based 
discrimination as follows:  
any distinction, exclusion or restriction on the basis of disability which has the purpose or effect 
of impairing or nullifying the recognition, enjoyment or exercise, on an equal basis with others, of 
all human rights and fundamental freedoms in the political, economic, social, cultural, civil or any 
                                               
75 Article 2 in CRPD defines reasonable accommodation as the “necessary and appropriate modification 
and adjustments not imposing a disproportionate or undue burden, where needed in a particular case, to 
ensure to persons with disabilities the enjoyment or exercise on an equal basis with others of all human 
rights and fundamental freedoms”. 
76 CRPD, Article 5.2. 
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other field.77  
A literal interpretation of this definition suggests that a practice must aim at, or have, a 
negative impact on the enjoyment or exercise of a human right in order for it to be 
discriminatory. As discussed above, the “right to participate in research” appears in 
neither the CRPD nor any other human rights treaty. This does not mean that the 
exclusion of persons with disabilities from research falls outside the scope of the 
Convention’s protection against discrimination, however. Article 5 of the CRPD is 
modelled on article 26 of the ICCPR,78 and since the late 1980s the Human Rights 
Committee has interpreted the latter as a freestanding prohibition on discriminatory 
domestic legislation and practices in any field regulated and protected by public 
authorities.79 The CRPD Committee has affirmed that article 5 must be interpreted in 
the same vein.80 In view of the purpose of the CRPD – which is to ensure that persons 
with disabilities enjoy the same level of protection of human rights as others – this seems 
reasonable.81  
 
If it is assumed that article 5 of the CRPD applies to research participation, the question 
becomes: would the exclusion of persons with disabilities from research participation 
constitute discrimination as defined in article 2? The answer appears to be that it would, 
if two criteria are met. First, the relevant exclusion must be based on reasons that are 
related to disability/impairment.82 The presence of a disability does not have to be the 
sole reason for exclusion, however. The prohibition of discrimination has been 
interpreted to cover also disadvantageous treatment based on reasons which appear to 
be neutral but have a disproportionate impact on persons with disabilities; this is often 
called indirect discrimination.83 A situation where ostensibly disability-neutral legal 
requirements make the inclusion of those with disabilities so cumbersome or costly that 
researchers avoid enrolling such persons would be a case in point (more examples will 
be given in the next section).  
 
Secondly, the exclusion must have a negative impact on those concerned.84 It can, of 
course, be questioned whether exclusion from research participation harms or 
disadvantages those excluded. The main purpose of research, after all, is to generate 
                                               
77 CRPD, Article 2. 
78 The first two paragraphs of article 5 of the CRPD are almost a carbon copy of article 26 of the ICCPR. 
79 See e.g. Human Rights Committee, ‘General comment No. 18: Non-discrimination’, adopted 10 
November 1989, HRI/GEN/1/Rev.9 (Vol. I), adopted 10 November 1989. In para. 12 the Committee 
states: “[a]rticle 26 does not merely duplicate the guarantee already provided for in article 2 but provides 
in itself an autonomous right. It prohibits discrimination in law or in fact in any field regulated and 
protected by public authorities. […] In other words, the application of the principle of non-discrimination 
contained in article 26 is not limited to those rights which are provided for in the Covenant.” 
80 CRPD Committee, ‘General comment No. 6 on equality and non-discrimination’, adopted 26 April 2018, 
CRPD/C/GC/6, para. 13.  
81 Vienna Convention on the Law of Treaties (1969), 1155 UNTS 331 [Adopted] 23rd May 1969; [Opened 
for Signature] 23rd May 1969; [Entered into Force] 27th Jan 1980, article 31.1. This provision affirms that 
treaty-based norms are to be interpreted in accordance with the “ordinary meaning” of the terms “in their 
context and in the light of its object and purpose”. 
82 In article 2 the CRPD defines discrimination as “any distinction, exclusion or restriction on the basis of 
disability” [our italics].  
83 CRPD Committee, ‘General comment No. 6’  (fn 80), para. 18(b). 
84 Article 2 in the Convention speaks of state practice that “has the purpose or effect of impairing or 
nullifying the recognition, enjoyment or exercise […] of human rights and fundamental freedoms” [our 
italics]. 
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new knowledge, not to promote the well-being or serve the interests of the individual 
participating in the study. Participating individuals devote time and effort to the projects 
in which they are involved, but those projects cannot be expected to yield any direct 
personal benefits for them, and from that perspective it may be more natural to think of 
research participation as, if anything, a burden. However, there are situations where 
enrolment in a study may offer the participant tangible benefits. For example, in medical 
research participants may be remunerated, receive superior health monitoring, learn 
more about their condition, and about ways to alleviate or cope with its negative effects, 
or receive some other "collateral" benefit. Participating in a clinical trial may also, on 
occasion, be the only way of gaining access to certain treatment, where no other 
therapeutic intervention is available or where the treatment being tested holds out some 
special promise. To participate in a pedagogical intervention study will sometimes be the 
only the way of getting access to a course taught with certain new and promising 
educational methods, and there might, for example, be no other way of being eligible 
for a particular program for occupational rehabilitation than to accept being enrolled in 
a research study of the effects of that program. 
 
A less tangible benefit, but possibly just as important, is that persons with disabilities, 
like others, may have an interest in contributing to society's pursuit of knowledge, just 
as they may have an interest in other ways of discharging their (self-perceived) moral 
obligations towards others.85 A fairly extensive corpus of literature suggests that 
participation in at least some kinds of research is indeed often based on altruistic 
considerations.86 Even when this is not the case, however, persons with disabilities may 
have an interest in the opportunity to participate simply because others have this option. 
That is, whether or not research participation, or pulling one's weight as a member of 
society, can be regarded as a benefit, arrangements which deny disabled persons 
opportunities that others have are, in themselves, negative for persons with disabilities.  
 
Finally, the exclusion of disabled persons from research for reasons related to 
disability/impairment may have wider deleterious effects: it could, for example, reinforce 
stereotypical images of persons with disabilities as people who are unable to make 
socially valued contributions to society, and eventually this may contribute to social 
exclusion.  
 
If we accept that persons with disabilities may benefit from research participation, or at 
least from having that option, depriving persons with disabilities of an opportunity to 
participate in research can certainly be viewed as a disadvantage. The next question is 
whether such disability-related disadvantageous practices can be justified under the 
CRPD. The treaty text is silent on this matter. So are other human rights treaties 
                                               
85 Recent jurisprudence from the Court of Justice of the European Union could be interpreted to support 
this view. In a case concerning a French regulation banning blood donations by men who have had or 
currently have sexual relations with other men, the Court held that men covered by the ban were treated 
“less favourably” than male heterosexual donors. The regulation therefore discriminated among potential 
donors based on sexual orientation and needed to be justified to not violate the prohibition on 
discrimination. Court of Justice, Léger v. Ministre des Affaires sociales, de la Santé et des Droits des 
femmes, C-528/13, ECLI: EU:C:2015:288, paras. 49-51. 
86 For a few recent examples, including further references, see Jennifer s. Carrera et al., 'Research Altruism 
as Motivation for Participation in Community-centered Environmental Health Research' (2018) 196 Social 
Science & Medicine 175-81, and Deborah Goodman et al., ‘Factors that Motivate Participation in 
Observational Genetic Cancer Research Studies’ (2019) 9 (2) Open Journal of Epidemiology 156-72. 
[2019] International Journal of Mental Health and Capacity Law 
 
19  
developed under the auspices of the UN. Still, these latter treaties have been interpreted 
so as not to outlaw every action which, strictly speaking, meets the definition of 
discrimination: practices pursuing a legitimate aim, based on “objective and reasonable 
criteria”, do not violate the prohibition of discrimination they set down.87 There are good 
arguments for the view that the CRPD’s prohibition of disability discrimination leaves 
room for a similar possibility of justification. This would accord with the drafter’s 
intentions and with the Convention’s purpose of ensuring that persons with disabilities 
enjoy the same human rights protection as others, and no state party has so far 
challenged it.88  
 
In Section 5 we will illustrate how argumentation about the legitimacy and lawfulness of 
research protocols that exclude persons with disabilities may play out. 
 
IV. POTENTIAL REASONS FOR EXCLUSION 
 
As a preliminary to the hands-on discrimination analysis to be presented in Section 5, it 
will be helpful to distinguish between different conceivable reasons why researchers, 
rightly or wrongly, may decide not to enrol persons with certain psychosocial, intellectual 
or cognitive disabilities in their studies. The rationale for such exclusions strongly bears 
on whether or not they can be justified, and hence their compliance with the prohibition 
on discrimination. Below, four types of rationale, or reason, are considered. In many 
cases, the exclusion of persons with disabilities for these reasons may well amount to 
discrimination in the sense prohibited by article 5. However, the goal of the discussion 
is not to determine whether any of the four reasons considered are discriminatory in this 
sense. It is rather to describe imaginary scenarios which add flesh to the general analysis 
of discrimination set out in Section 5. 
 
A. Exclusion based on protection  
 
Persons who might otherwise have been considered for inclusion in a research study 
could be excluded on grounds of protection. As has already been mentioned, key 
research ethics guidelines, declarations and conventions guarantee certain protections. 
Researchers could attempt to justify the exclusion of persons with disabilities by 
appealing to those safeguards. For example, a person with an intellectual disability may 
declare an interest in participating in a phase I drug trial, i.e. a trial designed to assess 
the safety of a drug in healthy volunteers. The person in question, it can be supposed, 
meets the general eligibility criteria for enrolment, with respect to age, sex, somatic 
health status, etc., but the researchers nevertheless decide not to include this person. 
Pointing to the fact a phase I trial involves risks, they determine that the person lacks 
the ability to provide informed consent and appeal to the prohibition against enrolling 
persons without decision-making capacity if the relevant research could be conducted 
with participants who are able to give consent.  
                                               
87 Anna Nilsson, ‘Article 2: Definitions’ in in Ilias Bantekas, Michael Ashley Stein and Dimitris Anastasiou 
(eds.) The UN Convention on the Rights of Persons with Disabilities: A Commentary (Oxford University 
Press, 2018), 75; and Rachele Cera, ‘Article 5 [Equality and Non-Discrimination]’ in Valentina Della Fina 
and Rachele Cera Giuseppe Palmisano (eds.) The United Nations Convention on the Rights of Persons 
with Disabilities: A Commentary (Springer, 2017), [160]. 
88 Anna Nilsson, ‘Objective and Reasonable? Scrutinising Compulsory Mental Health Interventions from a 
Non- discrimination Perspective’ (2014) 14 (3) Human Rights Law Review 459-85, [463-4]. 




In another scenario, researchers are recruiting participants for an evacuation study, 
targeting persons with mid-stage Alzheimer’s disease, and with the ultimate aim of 
designing and marking escape routes in a way adapted to the behaviour of this group 
and that of those with similar disabilities. In accordance with requirements in the 
standard codes of research ethics serving to protect research participants from tangible 
harm and exploitation, participants are enrolled with the consent of their loved-ones, 
who act as their legal representatives. However, those with no significant others – at all, 
or available – are excluded, again in line with the consideration not to include 
unrepresented persons without the ability to consent.89 Alternatively, the researchers 
may instead wish to enrol the potential participants under a support paradigm, but note 
in a particular case that none of the persons that could be asked to provide the relevant 
support for the person with Alzheimer’s is fit to fulfil that role. 
 
B. Exclusion based on methodological concerns  
 
Research is governed by various general scientific norms connected with its aim of 
generating sound results that can be trusted. Such norms guide researchers when they 
design their studies, and some of the methodological standards that have to be met 
relate, directly or indirectly, to participant selection. Researchers could, therefore, 
decide, on occasion, not to include persons with certain disabilities in order to guarantee 
the methodological quality of the research. For example, a subpopulation of those with 
psychosocial disabilities could be excluded if there are reasons to believe that this group 
runs a greater risk of dropping out from the study, since high attrition rates make it hard 
to obtain statistically significant results. Individuals could also be excluded on the basis 
that, with their level of cognitive impairment, they have poor prospects of fully following 
complex study instructions. Again, the chances of obtaining data which can be correctly 
interpreted may in some cases be judged slim. That may arise when a research interview 
would have to be conducted with the help of support (someone interpreting what the 
person with disabilities expresses). For that reason, or similar reasons, interview 
responses may be difficult for researchers to assess.  
 
Presumably, many methodological challenges can be met with appropriate training and 
resources (cf. below), but the possibility of an ineliminable tension between the goals of 
inclusion and scientific quality cannot be ruled out a priori.  
 
C. Exclusion based on perceived irrelevance to the research question  
 
Researchers’ choices to not include persons with a disability in their studies are 
sometimes best explained by the focus of their research questions. Researchers may be 
interested in doing human subject research on issues affecting groups which happen 
not to include persons with disabilities. For example, a study surveying the factors 
affecting the wellbeing of PhD students at top universities is unlikely to enrol those with 
significant cognitive disabilities. At times, however, failure to enrol persons with 
disabilities will be the result of ignorance about, or inattention to, the fact that such 
                                               
89 See e.g. the British Psychological Society, ‘Code of Human Research Ethics’ (fn 17), section 4, and 
Swedish Act concerning the Ethical Review of Research Involving Humans (fn 15), §22. Cf. also Oviedo 
Convention, Article 17.1(iv) and its Protocol on Biomedical Research, Article 15(iv). 
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persons are part of the population one is interested in – and that their experiences, 
needs, perspectives and so on, may be different from those that persons without 
disabilities have. These are cases where persons with disabilities may not be deliberately 
excluded, but where the researchers fail to see that considerations of representativeness 
dictate that such persons are included. 
 
D. Exclusion based on limited resources  
 
Finally, the involvement of persons with cognitive or psychosocial disabilities in research 
may be both time consuming and resource intensive, and researchers could for that 
reason decide to avoid it.90 In particular, offering potential participants the special 
protection that their impairments call for may (be believed to) raise costs and/or slow 
down the project. Adapting and monitoring the consent procedure, finding individuals 
prepared and able to provide decision-making support, and making thorough risk 
assessments that take into consideration the specific impairments and situation of those 
being considered for enrolment, are some of the measures that may (be believed to) 
present a challenge for researchers with promised or expected deliverables, deadlines 
and limited project budgets. Any measures requiring extra training, on the part of 
researchers, will typically tax resources. Additional "hurdles" in the form of tougher 
scrutiny by research ethics committees may also need to be reckoned with.91 
 
V. DISCRIMINATION ANALYSIS 
 
In Section 3, it was argued that the CRPD gives persons with disabilities the right to 
participate in research on an equal basis with others. This obviously applies to all kinds 
of research conducted at public universities and other academic institutions. Indirectly, 
it also applies to research conducted in private settings. According to article 4.1(e), state 
parties must "take all appropriate measures to eliminate discrimination on the basis of 
disability by any person, organization or private enterprise". This means that no 
researchers, public or private, are free to exclude persons with disabilities from research 
participation in discriminatory ways.92  
 
In order to determine whether a concrete case of exclusion from research participation 
violates or complies with the CRPD, one must consider the reasons for exclusion (cf. 
section 4). All research that excludes persons with disabilities for disability-related 
reasons must serve legitimate aims and be based on objective and reasonable criteria 
to comply with the Convention.93 Starting with the first of these conditions, the pursuit 
of a legitimate aim, it can be seen that in all of the imagined scenarios above researchers 
were motivated by legitimate aims. In the examples, the exclusions were intended to 
protect research subjects, to secure methodological quality, to pursue a particular 
research interest or to proceed on limited resources. All of these aims, in themselves, 
are compatible with the CRPD.  
                                               
90 As noted by Iacono and Carling-Jenkins (fn 4), researchers have complained about the over-regulation 
by ethics committees of research involving people with intellectual disabilities. 
91 Cf. Nancy A. Pachana et al., ‘Can We Do Better? Researchers’ Experiences with Ethical Review Boards 
on Projects with Later Life as a Focus’ (2015) 43 (3) Journal of Alzheimer’s Disease 701-7. 
92 Cf. CRPD Committee, Bacher v. Austria, Communication No. 26/2014, adopted 16 February 2018, 
CRPD/C/19/DR/26/2014, para. 9.3. 
93 Section 3.1. 




For exclusion of prospective research participants to be based on "objective" criteria, 
such exclusion must be relevant to – typically by contributing to – the (legitimate) aim.94 
Exclusion decisions must not be based on ignorance or (negligently) mistaken 
assumptions about the excluded group. It would, for example, be discriminatory to 
exclude persons who are blind, or deaf, on the basis of prejudicial assumptions about 
the cognitive abilities of such persons. Whether a given research protocol contributes to 
the aims in question is essentially an empirical matter that can only be answered 
definitively in relation to a concrete case. There is, however, little doubt that the 
exclusions of persons with disabilities in the examples given above serve the relevant 
aims in one way or another. Preventing persons with intellectual disabilities from 
participating in a phase I drug trial will, of course, protect this group from the risks 
associated with such participation. The same is true for persons with mid-stage 
Alzheimer's disease who are excluded from research enrolment because they lack legal 
representation. And in situations where funding for support and accommodation is 
lacking, excluding persons with certain disabilities can indeed be a way to ensure the 
methodological quality of the study.  
 
In addition to being (justifiably believed to be) instrumental to the achievement of 
legitimate aims, exclusions of persons with disabilities need to meet the criterion of 
reasonableness. This last step of the discrimination analysis serves to ensure that the 
practices under review are fair and do not produce consequences that are unduly 
burdensome for those affected.95  
 
Judgements on reasonableness take several considerations into account. These include 
the importance of the interests at stake, and the positive and negative effects of the 
practice under review.96 They also include the consideration of alternative ways to 
proceed meeting the same aims.97 There is no basis for making unqualified general 
statements about whether excluding persons with disabilities from research is 
reasonable. But to illustrate how reasoning about the reasonableness of exclusion can 
unfold, let us consider the first example provided in previous section. This example 
involves the exclusion of a person with an intellectual disability from enrolment in a 
phase I drug trial because he or she is believed to lack the ability to consent. (Similar 
considerations apply to the other conceivable grounds for excluding persons with 
disabilities.) The primary interests at stake here are, on the one hand, the interest of 
those with disabilities in being protected from certain harms, and, on the other hand, 
the interest of the same people in being considered as prospective research subjects 
and allowed to make their own choices about whether or not to get involved. Both 
interests are important, and the reasonableness of the decision to exclude the individual 
from the study hinges, by and large, on its positive and negative effects in view of 
alternative ways to achieve the positive outcomes and mitigate the negative 
consequences. 
                                               
94 Anna Nilsson, Minding Equality: Compulsory Mental Health Interventions and the CRPD (PhD thesis, 
Faculty of Law, Lund University, Media Tryck, 2017), [80]. 
95 Ibid., [81-85]. The UN treaty bodies have sometimes couched their reasoning about reasonableness in 
terms of “proportionality”. See e.g. CRPD Committee, H.M. v. Sweden, Communication No. 3/2011, 
adopted 19 April 2012, CRPD/C/7/D/3/2011, paras. 8.2 and 8.8. 
96 Nilsson (fn 94) 81f. 
97 Ibid., 82.  




As noted above, research protocols excluding any disabled person who does not fully 
understand the risks involved in research participation arguably protect those with 
disabilities from harms and burdens associated with research participation. A critical 
question here is whether a similar level of protection could be achieved by other means. 
One way to facilitate research participation without compromising the participant’s 
interest in protection is to provide decision-making support. Indeed article 12.3 of the 
CRPD obliges state parties to ensure that persons with disabilities have access to such 
support. Whether various support mechanisms could effectively enable free and 
informed consent in all situations where an individual wishes to participate is, however, 
an empirical question, one which cannot be settled by stipulation. The development of 
support mechanisms to aid people in their decision-making has only recently begun and 
there are good reasons to be optimistic about the future. A growing body of literature 
discusses the prospects of providing such support in various situations where personal 
decisions are to be made.98 But this is an area in which relatively little empirical research 
has been conducted, and it remains unclear whether the various forms of support being 
considered will meet the needs of all those currently being excluded from research 
participation for reasons of cognitive and mental impairment.  
 
In situations where the support provided fails to give the potential participant an 
adequate understanding of what study participation will involve, we need to balance the 
costs and benefits of the decision (or policy) under consideration to determine its 
reasonableness. Turning first to the benefits of exclusion, people vary in their cognitive 
abilities and decision-making skills. The reasons against including a particular participant 
in a research study are arguably weightier in situations where he or she does not 
understand the risks involved, or overestimates the chances of gaining direct health (or 
other) benefits from the project, than they are in situations where the lack of 
understanding concerns more peripheral information. In addition, research projects 
differ in the risks and burdens to which they expose their participants. While it seems 
fair to exclude persons lacking certain decision-making abilities from high-risk projects, 
it may be unreasonable to exclude the same group from participation in low-risk, low-
burden, studies where participants are, say, expected to answer a set of innocuous 
questions or will merely have a blood sample taken. The risk of instrumentalising those 
who do not fully understand what the research is about remains, of course, but the need 
for protection is arguably less in low-risk, low-burden studies than it is in studies that 
are more demanding for participants or expose them to more serious risks and burdens.  
 
A closer evaluation of the costs of exclusion would also be necessary. It would be 
important, for example, to ask whether the relevant study may involve direct benefits 
for those enrolled. As the Oviedo Convention, its Protocol on Biomedical Research, and 
the DoH all suggest, it may be unreasonable to exclude persons who cannot consent to 
research participation from studies that have the potential to produce real and direct 
                                               
98 Ex pluribus Michael Bach and Lana Kerzner, ‘A New Paradigm for Protecting Autonomy and the Right to 
Legal Capacity - Advancing Substantive Equality for Persons with Disabilities through Law, Policy and 
Practice’, prepared for the Law Commission of Ontario, 2010, 72ff and Piers Gooding, A New Era for 
Mental Health Law and Policy: Supported Decision-Making and the UN Convention on the Rights of Persons 
with Disabilities (Cambridge University Press, 2017), ch. 6. 
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health benefits to participants.99 Other benefits could also be considered. People choose 
to participate in research for a range of reasons,100 and whatever benefit a participant 
can be expected to obtain from his or her participation (clinical, psychological, 
educational or another sort), if this benefit could be significant, this too would have 
some bearing on the lawfulness of any exclusions. At the same time, it should be kept 
in mind that the main positive outcomes of research are not, in general, benefits to the 
research subjects, but rather benefits to science or society. Including persons with 
disabilities in research projects facilitates the development of technical aids and new 
services tailored to meet their needs. It also enables states to create more accessible 
and inclusive societies and thereby fulfil their treaty obligations under the CRPD.101 The 
more important that aim is considered to be, the greater is the probability that leaving 
persons with disabilities out of research studies will be considered unlawful. 
 
As the points above illustrate, judgements of reasonableness take a variety of 
considerations into account, among them: the availability of support enabling free and 
informed consent, the magnitude of the harms and burdens that the person may have 
to endure in the study, the tangible benefits that he or she may be deprived of if 
excluded, and the importance of the research project’s contribution to society. The fact 
that it can be very difficult to determine whether the potential participant understands 
the risks to which he or she will be exposed in a particular research project, or whether 
a given set of support measures enables free and informed decisions to be made, adds 
to the complexity of the matter. Similarly, the difficulties involved in determining the 
probability of the harms, burdens and possible benefits of a particular research project 
add to the complexity of any assessment of these harms, burdens and benefits. When 
the different considerations are being balanced, the certainty, or reliability, with which 
all of these assessments has been made arguably also needs to be taken into account. 
Where, for example, estimates of the expected benefits of a particular project, or the 
probability of their occurrence, rest on uncertain data, this will reduce the weight of the 
reasons in favour of including persons who are unable to consent. Conversely, if such 
estimates rest on certain information, that will strengthen the case for inclusion. 
 
To summarise, it is difficult, if not impossible, to provide a comprehensive answer to the 
question: under what circumstances can the exclusion of persons with disabilities from 
research participation be considered reasonable, and therefore lawful under the CRPD?  
 
Judgements of reasonableness can only be reached in the context of a particular study 
and a particular group of prospective study participants – where the weight of the 
reasons for and against participation are balanced against each other. As already 
mentioned, while the CRPD grants persons with disabilities many different rights, some 
of which do relate to protection against research enrolment, taken as a whole it can 
indeed be read as guidance intended to curb, among other things, paternalistic policies 
and attitudes. That is why special emphasis is given in the Convention to such interests 
as individual autonomy, and participation and inclusion in the community. Even on that 
                                               
99 Oviedo Convention, Article 17.1, and its Protocol on Biomedical Research, Article 15.1. DoH para. 28. A 
similar argument could be made with regard to other forms of direct benefits such as access to a particular 
educational method or program for occupational rehabilitation, see section 3.1. 
100 See e.g. Michael C. Soule et al., ‘Understanding Motivations to Participate in an Observational Research 
Study: Why Do Patients Enroll?’ (2016) 55 (3) Social Work in Health Care 231-46. 
101 Section 3. 
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reading, however, it is far from clear that this translates into these interests having 
decisively greater weight in the balancing of reasons for and against research enrolment 
– that is something that would have to be argued on a case-by-case basis.  
 
VI. CONCLUDING REMARKS 
 
The nature and scope of the basic rules governing research-based knowledge production 
and the rights of those who participate in it are critical issues for every society. Such 
rules must ensure that important research is made possible. They must also safeguard 
against unethical research: research that is unnecessary, flawed in its design, 
exploitative, or such that its potential benefits do not compensate for the risk of harm it 
introduces. The rules also need to be consistent with general norms of fairness, and in 
particular non-discrimination. How to reconcile these demands is a recalcitrant issue that 
every society will have to deal with. 
 
Sometimes explicitly, but in the main implicitly, the CRPD addresses all of the above 
demands. Article 15 outlaws medical and scientific experimentation without consent, and 
articles 5 and 16-17 prohibit research practices that are discriminatory, exploitative or 
violate research participants' integrity. As discussed above, the precise scope of this 
protection will remain unclear until there is agreement over what, in the CRPD, 
constitutes valid consent, and who can provide it.102 What is more, the CRPD arguably 
grants a right for persons with disabilities to participate in research. There is an 
obligation on states parties to conduct research involving members of this group and a 
duty to ensure that prospective research participants with disabilities have access to 
adequate decision-making support.103 In addition, the right to legal capacity gives 
persons with disabilities the right to decide whether or not to participate in research 
should an opportunity present itself.104  
 
Last but not least, the prohibition of discrimination embedded in the Convention outlaws 
research protocols that exclude persons with disabilities unless such exclusion can be 
justified, and the necessary justification requires careful consideration of a number of 
interests and considerations, all of which need to be balanced.105 
 
As a final note, researchers need to design CRPD-compliant non-discriminatory research 
protocols. Success in this endeavour will depend on further work on the implications of 
the CRPD for human subjects research. Additionally, codes of research ethics may need 
to be reworked, so as to better reflect the Convention's demand for equal treatment of 
those with and without disabilities while still achieving the codes’ key aims, i.e. the 
facilitation of important research and safeguarding against harm and exploitation. This 
is no easy task. Understanding these challenges better, and how best to meet them, is 
a matter for further research.  
 
  
                                               
102 Section 2.2. 
103 Section 3 and CRPD, Article 12.3. 
104 CRPD, Article 12.2. 
105 Sections 3.1 and 5.  
